Y Lu,
YT Chan, HY Tan, C Zhang, W Guo, Y Xu… - Journal of Experimental …, 2022 - Springer
Background Drug resistance to sorafenib greatly limited the benefits of treatment in patients
with hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) participate in the development …